KARYOPHARM THERAPEUTICS INC (KPTI)
US48576U1060 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -143.10M | -165.29M | -124.09M | -196.27M | -199.59M | |||
| Depreciation Amortization | 530.00K | 620.00K | 790.00K | 970.00K | 970.00K | |||
| Change In Working Capital | 31.41M | -19.99M | -23.19M | 1.34M | -13.31M | |||
| Interest Paid | 5.17M | N/A | N/A | N/A | N/A | |||
| Other non cash items | 18.43M | 35.11M | 39.37M | 33.73M | 21.10M | |||
| OPERATING CASH FLOW | -92.72M | -149.55M | -107.12M | -160.23M | -190.82M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -120.00K | -210.00K | -150.00K | -210.00K | |||
| Other Investing Activity | 7.94M | -104.14M | 142.05M | -53.54M | 78.66M | |||
| INVESTING CASH FLOW | 7.94M | -104.26M | 141.84M | -53.69M | 78.45M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 73.61M | |||
| Stock Issued/Repurchased | 1.12M | 193.74M | 13.65M | 172.08M | 50.70M | |||
| Other Financing Activity | 0.00 | 0.00 | 60.00M | N/A | N/A | |||
| FINANCING CASH FLOW | 1.12M | 193.74M | 73.65M | 172.08M | 124.31M | |||
| Exchange Rate Effect | -34.00K | -490.00K | -50.00K | 270.00K | 20.00K | |||
| CHANGE IN CASH | -83.69M | -60.56M | 108.32M | -41.57M | 11.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -92.72M | -149.55M | -107.12M | -160.23M | -190.82M | |||
| Capital Expenditure | 0.00 | -120.00K | -210.00K | -150.00K | -210.00K | |||
| FREE CASH FLOW | -92.72M | -149.67M | -107.33M | -160.38M | -191.03M | |||
All data in USD